Clinical AdvisorIs triamcinolone safe for seasonal allergies?Clinical AdvisorThe American Academy of Allergy, Asthma & Immunology does not recommend the use of systemic corticosteroids for allergic rhinitis; nasal steroids are considered the first-…
Topical use of corticosteroids by pregnant women appears not to be associated …Big News Network.comThe use of topical corticosteroids by pregnant women does not appear to be associated with pregnancy outcomes including orofacial cleft, low birth weig…
HealthDay |
Topical Corticosteroids Likely Safe During Pregnancy
Medscape Use of topical corticosteroids by pregnant women for skin conditions is unlikely to be associated with adverse fetal and maternal outcomes, according to a study published online September 4 in JAMA. Use of potent or very potent doses (≥300 g) of … Most pregnancy outcomes unaffected by topical corticosteroidsHealio Topical Cream and Healthy BabiesdailyRx Use of Low-Dose Steroid Creams During Pregnancy Won’t Affect Baby: StudyHealthDay |
Most pregnancy outcomes unaffected by topical corticosteroidsHealioUse of topical corticosteroids during pregnancy was not significantly associated with many adverse effects at birth, although low birth weight appeared to correlate with greater exposur…
|
Phase III Clinical Study Data Demonstrating LCP-Tacro(TM)’s Comparable …
MarketWatch (press release) HORSHOLM, Denmark, Sept. 4, 2013 /PRNewswire via COMTEX/ — Veloxis Pharmaceuticals A/S (omx:VELO) today announced that data from the 3002, randomized, double-blind, double-dummy, Phase III study in 543 de novo kidney transplant patients will … |
NOVARTIS AG : marks 30 year anniversary in transplantation and reinforces …4-traders (press release)The study of more than 2,000 patients will investigate de novo Certican + low dose CNI versus Mycophenolic Acid (MPA) + standard CNI, evaluating renal…
Vanderbilt adds genetic screening for drug tacrolimus to PREDICT programNews-Medical.netVanderbilt has added genetic screening for the drug tacrolimus to its personalize medicine pharmacogenomics program PREDICT. The new drug screening protocol was add…
|
Astellas Pharma launches once-daily oral tacrolimus formulation in US
Pharmaceutical Business Review The new product is indicated for the prophylaxis of organ rejection in patients receiving a kidney transplant used with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction. Astellas Pharma US president James Robinson … ASTELLAS PHARMA INC : ASTAGRAF XLTM (tacrolimus extended-release …4-traders (press release) Astellas’ Astagraf XL Launched in U.S. – Analyst BlogNASDAQ BIZ BRIEF: Astellas announces availability of Astagraf XL capsules in USAsahi Shimbun |
Oral Sirolimus Appears to Augment Efficacy of BMSTCTMDShort-term use of oral sirolimus after bare-metal stent (BMS) implantation reduces restenosis and repeat revascularization compared with stenting alone and may potentially match the efficacy of drug…
Immunosuppressants in Organ TransplantationThe Virtual Medical CentreInitially a specialist may give a corticosteroid and either Imuran (azathioprine) or mycophenolate (sometimes with a calcineurin inhibitors such as Prograf (tacrolimus) or Neoral (cyc…